Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation-Reference-Cited by-同舟云学术

Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation

Published:2015-08 Issue:8 Volume:46 Page:2168-2174
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Overvad Thure Filskov¹,Skjøth Flemming¹,Lip Gregory Y.H.¹,Lane Deirdre A.¹,Albertsen Ida Ehlers¹,Rasmussen Lars Hvilsted¹,Larsen Torben Bjerregaard¹

Affiliation:

1. From the Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Aalborg, Denmark (T.F.O., F.S., G.Y.H.L., L.H.R., T.B.L.); Department of Cardiology, Atrial Fibrillation Study Group, Aalborg University Hospital, Aalborg, Denmark (F.S., I.E.A., T.B.L.); and University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom (G.Y.H.L., D.A.L.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialised Nursing,Cardiology and Cardiovascular Medicine,Clinical Neurology

Reference38 articles.

1. Epidemiology of atrial fibrillation: European perspective

2. Meta-Analysis of Cohort and Case–Control Studies of Type 2 Diabetes Mellitus and Risk of Atrial Fibrillation

3. The Danish National Diabetes Register: trends in incidence, prevalence and mortality

4. Distribution and Risk Profile of Paroxysmal, Persistent, and Permanent Atrial Fibrillation in Routine Clinical Practice

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association of haemoglobin A1c variability with adverse outcomes in patients with atrial fibrillation prescribed anticoagulants;European Journal of Preventive Cardiology;2024-08-14

2. Lower Atrial Fibrillation Risk With Sodium-Glucose Cotransporter 2 Inhibitors Than With Dipeptidyl Peptidase-4 Inhibitors in Individuals With Type 2 Diabetes: A Nationwide Cohort Study;Korean Circulation Journal;2024

3. Safety of COVID-19 Vaccines among Patients with Type 2 Diabetes Mellitus: Real-World Data Analysis (Diabetes Metab J 2023;47:356-65);Diabetes & Metabolism Journal;2023-09-30

4. Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation: A report from the GARFIELD‐AF registry;Diabetes, Obesity and Metabolism;2023-07-12

5. Atrial fibrillation: primary prevention, secondary prevention, and prevention of thromboembolic complications: part 1;Frontiers in Cardiovascular Medicine;2023-06-15